ShanXi C&Y Pharmaceutical Group Co.,LTD.

SZSE:300254 Stock Report

Market Cap: CN¥2.2b

ShanXi C&Y Pharmaceutical GroupLTD Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 300254?
Owner TypeNumber of SharesOwnership Percentage
Institutions20,795,9118.36%
Individual Insiders44,608,70617.9%
General Public183,263,94673.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.9%.


Top Shareholders

Top 25 shareholders own 26.29% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.34%
Zhanguo Weng
15,772,409CN¥140.8m0%no data
5.51%
Qun Zhao
13,701,892CN¥122.4m2.24%no data
4.02%
Shanghai Tongyi Investment Management Co., Ltd
10,000,000CN¥89.3m0%2.16%
2.31%
Shandong Sanzu Private Placement Securities Investment Fund Management Co. Ltd
5,755,300CN¥51.4m0%no data
2.2%
Lequn Huang
5,465,060CN¥48.8m5.81%no data
1.25%
Hang Xuan
3,107,116CN¥27.7m0%no data
1.05%
Morgan Stanley, Investment Banking and Brokerage Investments
2,612,311CN¥23.3m0%no data
1.03%
Hairong Zhong
2,555,192CN¥22.8m13.3%no data
0.84%
Tong Hui Zhang
2,097,133CN¥18.7m0%no data
0.42%
Junxian Yu
1,036,800CN¥9.3m0%no data
0.28%
Zhong Ou Fund Management Co., Ltd
706,500CN¥6.3m0%no data
0.27%
Xue Min Zuo
677,931CN¥6.1m0%no data
0.17%
CCB Principal Asset Management Co., Ltd.
431,000CN¥3.8m0%0.01%
0.17%
Manulife Asset Management
416,900CN¥3.7m0%no data
0.13%
China Asset Management Co. Ltd.
325,400CN¥2.9m0%no data
0.052%
CITIC-Prudential Fund Management Company Ltd.
130,000CN¥1.2m0%0.01%
0.048%
Haibo Zhu
120,000CN¥1.1m0%no data
0.043%
Essence Fund Management Co., Ltd
107,800CN¥962.6k0%no data
0.032%
Hwabao WP Fund Management Co., Ltd
78,800CN¥703.7k0%no data
0.03%
Ying Min Yu
75,173CN¥671.3k0%no data
0.025%
China Southern Asset Management Co., Ltd.
61,200CN¥546.5k0%no data
0.023%
Western Leadbank Fund Management Co., Ltd.
58,200CN¥519.6k0%no data
0.016%
Bohai Huijin Securities Asset Management Co., Ltd.
39,600CN¥353.5k0%0.12%
0.016%
First State Cinda Fund Management Company Limited
38,800CN¥346.4k0%no data
0.0052%
E Fund Management Co., Ltd.
12,800CN¥114.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 02:47
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ShanXi C&Y Pharmaceutical Group Co.,LTD. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yalei YanBohai Securities Co., Ltd.
Jun LingPing An Securities Co. Ltd.
Xiao PengTX Investment Consulting Co., Ltd.